Elaine Schattner is a journalist, speaker, and former oncologist who lives in New York City. She is completing a book on attitudes toward cancer to be published by Columbia University Press. Her work examines the intersection of U.S. cancer care and charity, news including social media, and patient advocacy.
Dr. Schattner graduated from Yale College and earned a medical degree at the New York University School of Medicine. She completed a residency in Internal Medicine, followed by a combined fellowship in Hematology and Medical Oncology at the New York Presbyterian Hospital. In 1993, she joined the faculty at Weill Cornell Medical College. She led an NIH-funded cancer immunology lab, authored scientific papers and lectured on lymphoma, cell signaling and death pathways. She taught medical students, residents and fellows in hematology (blood diseases), oncology (cancer) and internal medicine.
A life-long patient with scoliosis, a history of early-stage breast cancer, arthritis and other chronic conditions, Elaine is a super-informed patient advocate who believes that all people deserve modern and compassionate health care. In 2009, she completed a master’s program at the Columbia University Graduate School of Journalism.
Her freelance work has appeared in the Atlantic, Cure Today, NPR, New York Observer, Pacific Standard, Slate, Washington Post, and elsewhere. As a Forbes contributor she covered novel cancer drugs, diagnostics and other biotechnology. Previously she authored a personal blog called Medical Lessons. She is a member of the American Society of Journalists and Authors.
Dr. Schattner is a Clinical Associate Professor of Medicine at Weill Medical College, where she belongs to the voluntary faculty. She is a Fellow of the American College of Physicians, a Fellow of the New York Academy of Medicine, a member of the American Society of Clinical Oncology, and a Distinguished Member Emeritus of the American Society of Hematology.
She’s a wife and mother who likes to read, swim and travel. Please follow Elaine on Twitter!